Antithrombin-III plasma levels in patients with venous leg ulcer disease
Munkvad, S.; Jørgensen, M.
Acta Dermato-Venereologica 75(3): 251
1995
ISSN/ISBN: 0001-5555 PMID: 7653195 Document Number: 451973
Document emailed within 1 workday
Related Documents
Nalçaci, M.; Pekçelen, Y. 1998: Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease Journal of International Medical Research 26(4): 206-208Litinskaia, E.V. 1977: Factors affecting vitamin B1, B6, PP and C levels in patients with ulcer disease Vrachebnoe delo 1977(6): 91-93
Weiler, H.; Weiler, C.; Gerok, W. 1990: Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects Netherlands Journal of Medicine 37(5-6): 189-196
Kooman, J.P.; Schalkwijk, C.G.; Konings, C.J. 2006: The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1 Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 410-411
Schulman, S.; Tengborn, L. 1992: Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III Thrombosis and Haemostasis 68(6): 634-636
Farhadi, D. 1997: Plasma homocysteine levels and mortality in patients with coronary artery disease New England Journal of Medicine 337(22): 1632; Author Reply 1632-1633
Selivonenko, V.G.; Piasetskiĭ, I.S. 1971: Plasma and erythrocyte levels of calcium and magnesium in patients at various stages of hypertensive disease Sovetskaia Meditsina 34(5): 140-142
Scalvini, S.; Volterrani, M.; Vitacca, M.; Clark, A.L.; Solfrini, R.; Panzali, A.M.; Ferrari, R.; Levi, G.F. 1996: Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease Monaldi Archives for Chest Disease 51(5): 380-386
Langmann, P.; Hubert, C.; Heinz, W.; Trein, A.; Schnaitmann, E.; Leyh, M.; Klinker, H.; Winzer, R. 2008: Safety of long-term lopinavir plasma-levels in patients with liver disease European Journal of Medical Research 13(5): 205-208
Innerfield, I.; Goldbloom, A.A.; Boyd, L.J. 1958: Plasma antithrombin elevations in buccal varidase-treated patients Surgery 43(6): 956-958
Da Silva, M.J.; Netto, M.P.; Kedor, H.H.; Camargo, P.A.; Kiss, M.A.; Giannini, S.D.; Deperon, S.D. 1988: Influence of physical activity on plasma levels of lipids and lipoproteins in patients with coronary disease Arquivos Brasileiros de Cardiologia 50(4): 231-236
Zhu, J.Z.; Chen, S.L.; Cui, Z.C. 1991: Dynamic investigation of antithrombin IIi in the plasma of patients with acute myocardial infarction Zhonghua Nei Ke Za Zhi 30(12): 746-748; 789
von Felten, A. 1992: Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex Therapeutische Umschau. Revue Therapeutique 49(12): 837-842
Torkhovskaia, T.I.; Khalilov, E.M.; Oleĭnik, I.A.; Kliuchnikova, Z.I.; Klimov, A.N. 1989: Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption Kardiologiia 29(10): 60-64
Emmungil, H.; Durusoy, R.; Kalfa, M.; Yargucu Zihni, F.; Özmen, M.; Keser, Gökhan.; Gücenmez, S.; Yilmaz, Z.; Aksu, K. 2015: Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease Clinical and Experimental Rheumatology 33(6 Suppl. 94): S40-S45
Del Dotto, P.; Colzi, A.; Pardini, C.; Lucetti, C.; Dubini, A.; Grimaldi, R.; Bonuccelli, U. 1995: Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients Journal of Neural Transmission. Supplementum 45: 259-265
Tomczykowska, M.łg.; Bielak, J.; Bodys, A. 2003: Evaluation of platelet activation, plasma antithrombin IIi and alpha2-antiplasmin activities in hypertensive patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 15-20
Kuhn, E.; Lodin, Z.; Lovacký, S.; Tauber, O.; Zizkovský, V.; Dvorák, P.; Srajer, S.; Skála, I. 1986: Plasma beta-endorphin immunoreactivity (PL-beta-ED-ir) in patients with ulcer disease and its management by acute and chronic administration of gastrozepin Hepato-Gastroenterology 33(1): 23-26
Mercuri, F.; Giacomello, R.; Puglisi, F.; Colaone, R.; Fabbro, D.; Menegon, M.G.; Ceriello, A.; Gonano, F.; Damante, G. 2000: Factor V leiden increases plasma F1+2 levels both in normal and deep venous thrombosis subjects Haematologica 85(4): 386-389
Márk, L.ás.ó; Márki-Zay, J.án.; Orosz, I.án.; Kondacs, A.ás.; Erdei, F.; Katona, A.ás. 2003: Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease Orvosi Hetilap 144(16): 765-768